CTRI/2023/08/056528尚未招募2 期
Phase-II â?? Non Randomized Clinical Study on Maantha sanni (Autism spectrum disorder) with the evaluation of Siddha trail drug Maantha maathirai(Internal) and Sanni thiri pugai(External) - Nil
Government Siddha medical college0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children have lack of eye contact
- •Lack of response
- •Repetitive or restricted behaviour
- •Unawareness of natural urges
- •Acquired speech or lost it
- •Unusual sensitive to sensory stimuli
排除标准
- •Children above 12 years
- •Children below 2 years
- •Severe and recurrent Seizures
- •Cerebral palsy
- •Infantile hemiplegia
- •Congenital anomalies
研究者
相似试验
尚未招募
2 期
clinical study using siddha medicine for Autism spectrum disorderCTRI/2024/06/069064Government Siddha Medical College
尚未招募
2 期
Study for Cerebral Palsy Using Siddha MedicineCTRI/2024/06/069667Government Siddha Medical College
尚未招募
2 期
Paandu Kudineer For Paandu Noi(Iron Deficiency Anaemia)CTRI/2021/07/034536Government Siddha Medical College
进行中（未招募）
1 期
A study to evaluate the switch from prednisone to dexamethasone in prostate cancer patients being treated with abirateroneEUCTR2021-000943-30-ESSOGUG (Spanish Genitourinary Oncologic Group)110
招募中
2 期
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with tri-weekly docetaxel (D) followed by doxorubicin, 5-fluorouracil, and cyclophosphamide (FEC) or docetaxel with concurrent use of capecitabine (TX) followed by doxorubicin, cyclophosphamide, and capecitabine (CEX) in women with locally advanced triple-negative breast cancerntreated women with triple negative breast cancer (T1c-4NxM0)JPRN-UMIN000018722Japanese Red Cross Society Himeji Hospital84